期刊文献+

度洛西汀合并小剂量喹硫平治疗伴躯体症状抑郁症的对照研究 被引量:11

Observation of duloxetine combined with small dose of quetiapine in the treatment of depression with somatic symptoms
原文传递
导出
摘要 目的评价度洛西汀合并小剂量喹硫平治疗伴躯体症状抑郁症的疗效和安全性。方法将68例伴躯体症状的抑郁症患者随机分为2组,对照组单用度洛西汀治疗,试验组度洛西汀合并小剂量喹硫平治疗,治疗8周。治疗前,治疗后1,2,4,8周用汉密尔顿抑郁量表(HAMD-24)评定疗效及药物副反应量表(TESS)评定不良反应。结果试验组有效率94.1%,明显高于对照组的76.5%,差异有统计学意义(P<0.05)。合并喹硫平后无力、困倦等不良反应增加,但多在1周内减轻。结论度洛西汀合并小剂量喹硫平治疗伴躯体症状抑郁症可提高有效率,叠加的不良反应轻微。 Objective To explore the efficacy and safety of duloxetine combined with small dose of quetiapine in the treatment of depression with somatic symptoms. Methods Sixty - eight cases of depression with somatic symptoms were randomly divided into two groups, one group was treated with duloxetine, and the other was treated with duloxetine com- bined with small dose of quetiapine. Treatment for before treatment and after 1, 2, 4, 8 weeks,the efficacy and safety were evaluated with Ham- ilton Depression Scale - 24 ( HAMD - 24 ) and Treatment Emergent Symptom Scale (TESS). Results The effect rate in the research group was 94. 1% , higher than that of the control group of 76.5%, which of two groups had significant difference. Side effects increased after treating with quetiapine, but loss within a week, such as weakness, drowsiness. Conclusion Duloxetine combined with small dose of quetiapine in the treatment of depression with somatic symptoms can improve the efficiency and side effects of treatment are mild.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2012年第10期726-727,733,共3页 The Chinese Journal of Clinical Pharmacology
关键词 度洛西汀 喹硫平 抑郁症 躯体症状 duloxetine quetiapine depression somatic symptoms
  • 相关文献

参考文献7

二级参考文献64

  • 1金俊,吴华玲,周忠莲,邓龙,张峰.文拉法辛与丙米嗪治疗抑郁症对照观察[J].临床精神医学杂志,2005,15(6):364-365. 被引量:5
  • 2孙群星,杨桂兰,李素华,朱玉星,张爱荣,刘智慧,程英.奎硫平合并阿米替林治疗难治性抑郁症临床研究[J].临床精神医学杂志,2006,16(2):106-106. 被引量:12
  • 3国效峰,赵靖平,陈晋东.度洛西汀:一种新型抗抑郁药[J].中国新药与临床杂志,2006,25(7):552-555. 被引量:88
  • 4IYENGAR S, WEBSTER AA, HEMRICK-LUECKE SK, et al. Efficacy of duloxetine, a potent and balanced serotonin-norepine- phrine inhibitor in persistent pain models in rats[J]. J Pharmacol Exp Ther, 2004, 311(2): 576-584.
  • 5RABASSEDA X. Duloxetine-a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression[J]. Drugs Today (Bare), 2004, 40 (9): 773-790.
  • 6WONG DT, BYMASTER FP. Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?[J]. Prog Drug Res, 2002, 58 : 169-222.
  • 7PERAHIA DG, PRITCHETT YL, DESAIAH D, et al. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?[J]. Int Clin Psychopharmacol, 2006, 21 (6) : 311-317.
  • 8RASKIN J, PRITCHETT YL, WANG F, et al. A double-blind, randomized muhicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain [J]. Pain Med, 2005, 6(5) : 346-356.
  • 9REN K, DUBNER R. Descending modulation in persistent pain : an update[J]. Pain, 2002, 100(1-2) : 1-6.
  • 10SINDRUP SH, JENSEN TS. Efficacy of pharmacological treatments of neuropathie pain: an update and effect related to meeh-anism of drug action[J]. Pain, 1999, 83(3) : 389-400.

共引文献51

同被引文献122

  • 1朱羞阳,佟洋,李驰荣.选择性5-羟色胺再摄取抑制剂与奥氮平联合治疗难治性抑郁症的临床疗效[J].东南国防医药,2013,15(2):125-127. 被引量:11
  • 2李坤艳,李焕德.HPLC-MS/ESI^+测定人血浆中喹硫平及其代谢产物[J].中南药学,2006,4(2):88-91. 被引量:9
  • 3单春杰,郭蓄芳,苏静,李奕.抑郁症患者主观幸福感的对照研究[J].精神医学杂志,2007,20(2):84-85. 被引量:9
  • 4杨红君,周世杰.几个常用执行功能测验在抑郁症中的应用[J].中国临床心理学杂志,2007,15(4):430-434. 被引量:18
  • 5Nierenberg AA, Katj BS,Fava M. A critical overview of thepharmaco-logic mangenent of trentment remission depression( J]. Psychiatrclin NAm,2007,30(6) : 13-29.
  • 6Cupta s, Nihalani N , Masand P. Duloxetine: review of its pharmacolo-gy, and therapeutic use in depression and other psychiatric disordem[J]. Ann Clin Psychiatry,2007,19(2) :125-132.
  • 7万争艳,李宁,韩兴玲.左旋甲状腺素联合度洛西汀、喹硫平治疗伴有精神症状的女性抑郁症的临床观察[J].中国医学科学,2012,2(15) :70-71.
  • 8Bairett B, Holcapek M, Huclov6 J, et al. Validated HPLC-MS/MSmethod for determination of quetiapine in human plasma [J]. J PharmBiomed Anal,2007 Jun 28,44(2) :498-505. Epub 2007 Apr4.
  • 9Chae JW, Baek HM, Kim SK. et al. Quantitative determination of du-loxetine and its metabolite in rat plasma by HPLC-MS/MS[J]. BiomedChromatogr,2013 Aug,27(8) :953-5.
  • 10Li X ,Xing B, Yu E ,et al.The combined treatment of ven- lafaxine and quetiapine for treatment-resistant depression: a clinical study[J].J Neuropsychiatry Clin Neurosci, 2013 Spring,25(2) : 157-160.

引证文献11

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部